Back to Rankings

BIOA

BioAge LabsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
BIOA vs peer average
84/100
BIOA vs. peer average (A vs. C)
Grade spread
B 3 · C 3 · D 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

OLMA is the first available peer comparator.

Olema Pharmaceuticals is a closer small-cap clinical-stage biotech peer by stage and market cap, useful mainly for comparing binary trial-execution risk and financing dependence rather than mechanism or indication overlap.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerOLMAOlema
BIOA
BioAge Labs
OLMA
Olema
Grade
A
C
Momentum
94
19
Value
46
41
Sentiment
54
97
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs OLMA

BIOA / OLMA
Grade Position
Above peers
BIOA vs. peer average (A vs. C)
84/100
Momentum
94
BIOA
Value
46
BIOA
Sentiment
54
OLMA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BIOA
1
OLMA
OLMA
C
60/100
+2
2
LXRX
LXRX
D
40/100
+3
3
DBVT
DBVT
C
60/100
+2
4
PCRX
Pacira Biosciences Inc Common
B
80/100
+1
5
AVTX
Avalo Therapeutics Inc Common
C
60/100
+2
OLMA is the first peer returned for this comparison set.